Skip to search formSkip to main contentSkip to account menu

pancopride

Known as: (+/-)-4-Amino-5-Chloro-Alpha-Cyclopropyl-N-3-Quinuclidinyl-O-Anisamide, Benzamide, 4-Amino-N-1-Azabicyclo(2.2.2)Oct-3-Yl-5-Chloro-2-(Cyclopropylmethoxy)-, (+/-)-, N-(1-azabicyclo(2.2.2)oct-3-yl)-2-cyclopropylmethoxy-4-amino-5-chlorobenzamide 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

BenzamidesBridged Bicyclo Compounds, Heterocyclic

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
Prevention of Highly Emetogenic Chemotherapy-Induced Vomiting: A Double Blind, Randomized Crossover Study to Compare Pancopride (LAS 30451) and Pancopride plus Dexamethasone
Aims Pancopride (PNC) is a new 5HT3 receptor antagonist which has demonstrated complete protection from nausea and vomiting in 25… 
1995
1995
Single dose pharmacokinetics and tolerance of pancopride in healthy volunteers.
Pancopride (LAS 30451, CAS 121650-80-4) is a new selective 5-hydroxytryptamine3 receptor antagonist which has demonstrated… 
1994
1994
Repeated dose pharmacokinetics of pancopride in human volunteers
The aim of this study was to assess the pharmacokinetic profile of pancopride after repeated oral dose administration of 20 mg… 
1994
1994
Pharmacokinetic studies of pancopride in rat and dog
1994
1994
[The clinical development of an antiemetic in oncology. A meta-analysis].
BACKGROUND To perform meta-analysis (MT) on antiemetic efficacy of LAS 30451 (Pancopride) in high and moderately emetogenic… 
1992
1992
Pancopride, a potent and long-acting 5-HT3 receptor antagonist, is orally effective against anticancer drug-evoked emesis.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)